Pathophysiological Process
The disease is based on marked suppression of hematopoiesis in the bone marrow. The primary issue is impaired proliferation and differentiation of hematopoietic stem cells. Due to the arrest of these processes, profound pancytopenia develops in the peripheral blood.
Clinical Manifestations
Patients experience severe clinical manifestations caused by blood cell deficits:
- Severe hypoxemic syndrome due to red blood cell deficiency.
- Hemorrhagic syndrome manifesting as an increased bleeding tendency.
- Secondary immunodeficiency leading to frequent infectious complications.
It is important to remember that splenomegaly is not characteristic of this condition.
Laboratory and Morphological Findings
Key changes are identified through blood and bone marrow examination:
- Bone marrow trephine biopsy: hematopoietic tissue is massively replaced by fat, with only small islands of myeloid tissue remaining.
- Peripheral blood: erythrocytes remain normocytic or macrocytic and normochromic, but reticulocytes are completely absent.
Differential Diagnosis and Special Forms
The condition must be differentiated from several other states, including preleukemic conditions and myelodysplastic syndrome (MDS).
Special attention is drawn to myelophthisic anemia, which clinically resembles aplastic anemia. It occurs in the setting of myelofibrosis, granulomatous diseases, or tumor metastasis to the bone marrow.
Among the special forms, pure red cell aplasia is distinguished, which is more commonly diagnosed in adults and is frequently associated with a benign thymoma.